Relay Therapeutics, Inc. RLAY

US Biotechnology

$20.03 ▼ -1.77% ($-0.36)

🔥 High Short Interest

Open $20.23

Prev Close $20.39

Day Range $19.97 – $20.97

52W Range $5.95 – $21.27

Market Cap $4.51B

Beta 1.70

EPS (TTM) $-1.57

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-07-16
Shares Out.	219,140,000
Website	relaytx.com/ ↗
Phone	13026587581
Employees	218
Revenue	$0
Gross Profit	$0
Net Income	-$81.7M
Free Cash Flow	-$214.0M
Total Assets	$901.7M
Total Liabilities	$82.7M
Equity	$819.0M

About Relay Therapeutics, Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Relay Therapeutics, Inc. is a publicly traded company under the ticker symbol RLAY on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.